BG103197A - Антитромботични азациклоалкилалканоил пептиди и псевдопептиди - Google Patents

Антитромботични азациклоалкилалканоил пептиди и псевдопептиди

Info

Publication number
BG103197A
BG103197A BG103197A BG10319799A BG103197A BG 103197 A BG103197 A BG 103197A BG 103197 A BG103197 A BG 103197A BG 10319799 A BG10319799 A BG 10319799A BG 103197 A BG103197 A BG 103197A
Authority
BG
Bulgaria
Prior art keywords
pseudopeptiees
antithrombotic
preparation
relates
azacycloalkylalkanoyl peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
BG103197A
Other languages
English (en)
Inventor
Scott Klein
Bruce MOLINO
Mark Czekaj
Charles Gardner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Publication of BG103197A publication Critical patent/BG103197A/bg
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретението се отнася до нехигроскопична стабилна кристална форма на антитромботичното съединениеN-[N-[N-(4-пиперидин-4-ил)бутаноил)-N-етилгликил]-(L)-аспартоил]-(L)- -циклохексилаланин амид, до метод за получаването й, до фармацевтичен състав нанейна база и до нейни междинни продукти. Изобретението се отнася и до метод и полупродукти за получаване на съединение с формула в която A, B, Z, E1, E2, G, R, m, n и р имат значенията, посочени в описанието.
BG103197A 1996-08-21 1999-02-22 Антитромботични азациклоалкилалканоил пептиди и псевдопептиди Pending BG103197A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/700,950 US5780590A (en) 1993-10-15 1996-08-21 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
PCT/US1997/014578 WO1998017678A1 (en) 1996-08-21 1997-08-15 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides

Publications (1)

Publication Number Publication Date
BG103197A true BG103197A (bg) 2000-05-31

Family

ID=24815484

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103197A Pending BG103197A (bg) 1996-08-21 1999-02-22 Антитромботични азациклоалкилалканоил пептиди и псевдопептиди

Country Status (21)

Country Link
US (1) US5780590A (bg)
EP (1) EP0929572A4 (bg)
JP (1) JP2001501965A (bg)
KR (1) KR20000035797A (bg)
CN (1) CN1231671A (bg)
AP (1) AP904A (bg)
AU (1) AU722112B2 (bg)
BG (1) BG103197A (bg)
BR (1) BR9711205A (bg)
CA (1) CA2263732A1 (bg)
EA (1) EA001391B1 (bg)
HU (1) HUP9903961A3 (bg)
IL (1) IL128556A0 (bg)
NO (1) NO990836L (bg)
NZ (1) NZ334059A (bg)
OA (1) OA10975A (bg)
PL (1) PL331713A1 (bg)
SK (1) SK14699A3 (bg)
UA (1) UA48252C2 (bg)
WO (1) WO1998017678A1 (bg)
ZA (1) ZA977511B (bg)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274705B1 (en) 1996-05-02 2001-08-14 Aventis Pharmaceuticals Products Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
ZA977510B (en) * 1996-08-21 1998-05-21 Rhone Poulenc Rorer Pharma Stable non-hygroscopic crystalline form of N-[N-[N-(4-(piperidin-4-yl)butanoyl)-N-ethylglycyl]aspartyl]-L-Betacyclohexyl alanine amide, intermediates thereof, and preparation thereof and of antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides.
WO1999019294A1 (en) * 1997-05-14 1999-04-22 Aventis Pharmaceuticals Products Inc. Legal/Patents Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides
EP1030831A4 (en) * 1997-10-10 2003-01-02 Aventis Pharm Prod Inc PREPARATION OF AZACYCLOALKYLALCANOYL PSEUDOTETRAPEPTIDES
AU2844800A (en) * 1998-12-30 2000-07-24 Aventis Pharmaceuticals Products Inc. Process for preparing a stable non-hygroscopic crystalline n-(n-(n- piperdin- 4-yl)butanoyl)- n.ethylglycyl)- (l)-aspartyl) -ss-cyclohexylalanine amide
US7200838B2 (en) * 2000-12-20 2007-04-03 National Instruments Corporation System and method for automatically generating a graphical program in response to a state diagram
US7544681B2 (en) 2001-09-27 2009-06-09 Ramot At Tel Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
CA2610838A1 (en) * 2005-06-07 2006-12-14 Ramot At Tel Aviv University Ltd. Novel salts of conjugated psychotropic drugs and processes of preparing same
US8377990B2 (en) 2006-07-17 2013-02-19 Ramot At Tel-Aviv University Ltd. Conjugates comprising a psychotropic drug or a GABA agonist and an organic acid and their use in treating pain and other CNS disorders
US8207369B2 (en) 2008-02-11 2012-06-26 Ramot At Tel-Aviv University Ltd. Conjugates for treating neurodegenerative diseases and disorders
EP2509603A1 (en) 2009-12-09 2012-10-17 Biolinerx Ltd. Methods of improving cognitive functions
EP2539857A4 (en) 2010-02-24 2013-07-24 Univ Ramot CRYSTALLINE FORMS OF PERPHENAZINE GABA TRIMESYLATE SALT AND PROCESS FOR PRODUCTION THEREOF
WO2012038963A1 (en) 2010-09-22 2012-03-29 Ramot At Tel-Aviv University Ltd. An acid addition salt of a nortriptyline-gaba conjugate and a process of preparing same

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821188A (en) * 1972-06-14 1974-06-28 American Home Prod Proline and pyroglutamic acid containing tripeptides
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
US4683291A (en) * 1985-10-28 1987-07-28 Scripps Clinic And Research Foundation Platelet binding inhibitors
FR2608160B1 (fr) * 1986-12-15 1989-03-31 Inst Nat Sante Rech Med Nouveaux derives peptidiques et leur application notamment en therapeutique
US4857508A (en) * 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
US5037808A (en) * 1988-07-20 1991-08-06 Monsanto Co. Indolyl platelet-aggregation inhibitors
US4992463A (en) * 1988-07-20 1991-02-12 Monsanto Company Thienyl peptide mimetic compounds which are useful in inhibiting platelet aggregation
US4879313A (en) * 1988-07-20 1989-11-07 Mosanto Company Novel platelet-aggregation inhibitors
US5023233A (en) * 1989-07-28 1991-06-11 Merck & Co., Inc. Fibrinogen receptor antagonists
CA2066047A1 (en) * 1989-09-29 1991-03-30 Scott I. Klein Anti-thrombotic peptides and pseudopeptides
US4952562A (en) * 1989-09-29 1990-08-28 Rorer Pharmaceutical Corporation Anti-thrombotic peptides and pseudopeptides
US5051405A (en) * 1989-10-10 1991-09-24 Rhone-Poulenc Rorer Pharmaceuticals Inc. Anti-thrombotic peptides and pseudopeptides
US5053392A (en) * 1989-12-01 1991-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Novel arginine, glycine, aspartic acid derivatives as platelet-aggregation inhibitors
US5086069A (en) * 1990-02-05 1992-02-04 Rorer Pharmaceutical Corporation Anti-thrombotic peptide and pseudopeptide derivatives
CA2037153A1 (en) * 1990-03-09 1991-09-10 Leo Alig Acetic acid derivatives
GB9007751D0 (en) * 1990-04-05 1990-06-06 Ciba Geigy Ag Novel platelet-aggregation inhibitors
US5064814A (en) * 1990-04-05 1991-11-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Anti-thrombotic peptide and pseudopeptide derivatives
NZ239876A (en) * 1990-09-27 1993-12-23 Merck & Co Inc Glycyl-b-alanine derivatives and pharmaceutical compositions thereof.
IL99539A0 (en) * 1990-09-27 1992-08-18 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical compositions containing them
MX9201416A (es) * 1991-03-28 1992-10-01 Rhone Poulenc Rorer Int Peptidos y pseudopeptidos antitromboticos.
WO1992018117A1 (en) * 1991-04-11 1992-10-29 Rhone-Poulenc Rorer International (Holdings), Inc. Anti-thrombotic peptide and pseudopeptide derivatives
DK0513675T3 (da) * 1991-05-13 1996-09-30 Fujisawa Pharmaceutical Co Hidtil ukendt peptidforbindelse samt fremgangsmåde til fremstilling deraf
RO115520B1 (ro) * 1993-10-15 2000-03-30 Rhone Poulenc Rorer Pharma Derivati peptidici azacicloalchilalcanoil si intermediari pentru obtinerea acestora

Also Published As

Publication number Publication date
HUP9903961A3 (en) 2000-12-28
OA10975A (en) 2001-11-01
BR9711205A (pt) 1999-08-17
AU4074997A (en) 1998-05-15
NO990836D0 (no) 1999-02-22
JP2001501965A (ja) 2001-02-13
HUP9903961A2 (hu) 2000-04-28
CN1231671A (zh) 1999-10-13
IL128556A0 (en) 2000-01-31
AP904A (en) 2000-11-24
EA001391B1 (ru) 2001-02-26
AU722112B2 (en) 2000-07-20
AP9901452A0 (en) 1999-03-31
NZ334059A (en) 2000-01-28
US5780590A (en) 1998-07-14
SK14699A3 (en) 2000-11-07
WO1998017678A1 (en) 1998-04-30
ZA977511B (en) 1998-03-03
CA2263732A1 (en) 1998-04-30
EP0929572A1 (en) 1999-07-21
EP0929572A4 (en) 2001-09-12
PL331713A1 (en) 1999-08-02
UA48252C2 (uk) 2002-08-15
KR20000035797A (ko) 2000-06-26
NO990836L (no) 1999-04-20
EA199900216A1 (ru) 1999-08-26

Similar Documents

Publication Publication Date Title
MY121908A (en) 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them.
BG103225A (bg) Стабилна нехигроскопична кристална форма на n-[n-n-(4-пиперидин-4-ил) бутаноил)-n-етилглицил] съединения
WO1996040757A3 (en) Lhrh antagonist peptides
EP0831100A4 (en) NEW PEPTIDE DERIVATIVES
IL139825A0 (en) Novel cyclosporins
IL129555A (en) Pharmaceutical compositions containing n-(oxoacetyl)-amino acid amide derivatives for stimulating neurite growth
NZ296479A (en) Amino acid or peptide derivatives which are inhibitors of multicatalytic protease (mcp)
BG103197A (bg) Антитромботични азациклоалкилалканоил пептиди и псевдопептиди
NZ279397A (en) Mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives and pharmaceutucal compositions
HUP9603237A3 (en) Crystalline hydrochloride of (r)-(-)-2-{n-[4-(1,1-dioxydo-3-oxo-2,3-dihydro-benzisothiazo-2-yl)-butyl]-amino-methyl}-chromane, process for the preparation thereof and pharmaceutical compositions containing them
HK1018742A1 (en) Preparation containing a combination of 5-methylisoxazole-4-carboxyclic acid-(4-triflouromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide
IL108797A0 (en) Amino acid derivatives, their preparation and pharmaceutical compositions containing them
AU4363199A (en) Use of hmg proteins for the preparation of medicaments having cytotoxic activity
RU94022277A (ru) Новые 19-норстероиды, имеющие в положении 11 - бета феноксиалкилсульфонамидную или феноксиалкилсульфонилкарбамидную цепь, метод и промежуточные продукты их получения, и содержащая их фармацевтическая композиция
MY120683A (en) New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals.
AU6611696A (en) N-(4-substituted-benzyl)-2-aminolactam derivatives
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
IL112630A (en) Derivatives of (2-(ar)alkyldithioindane-2-carboxamido) tricyclic-oxobenzazepine and similar compouds useful as inhibitors of enkephalinase, their preparation and pharmaceutical compositions containing them
IL89538A0 (en) Peptides,their preparation and pharmaceutical compositions containing them
AU3524993A (en) Method of peptide synthesis and new synthesis intermediates
ZA979645B (en) Heterocyclic compounds, compositions and uses.
DK0805817T3 (da) Thiolderivater med metallopeptidaseinhiberende aktivitet
ES8705847A1 (es) Procedimiento para preparar nuevos derivados de n-(2-hidro- xialquil)-aminoacidos
GB9604518D0 (en) Novel compounds
ES8703455A1 (es) Procedimiento para preparar n-(-(1'-alil-2'-pirrolidinil)- metil)-2-metoxi-4,5-azimido-benzamida a escala industrial